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Abstract 
Porcine Enteropathy also known as ileitis in pigs , caused by Lawsonia intracellularis, is regarded 
as one of the major gut related health issues in pork production. Recent reports from national 
institutes for pharmaceutical products show that the annual amount of antibiotics against enteric 
diseases has increased over the last few years. Despite the ban of antimicrobial growth promoters 
in Europe since January 2006, the total amount of antibiotics used in pigs does not seem to be 
significantly reduced . This is contradictory to the demands of the consumers for a reduction in 
antibiotic use and the efforts to reduce the risk of antibiotic resistance. Recently several field 
studies have demonstrated that the use of Enterisd' ileitis (Boehringer lngelheim), a vaccine 
against ileitis can reduce the amount of antibiotics needed to prevent this disease. Additionally, 
vaccination can contribute to the overall reduction in use of antimicrobials on farms due to the 
higher health status of the farms. This oral vaccine is therefore a better alternative compared to 
antibiotics to prevent ileitis. 
Introduction 
In the past few years. the political situation on antimicrobial use in agriculture has changed. 
According to Wagstrom (2006), ''the issue of antimicrobial use in food animals has in many ways 
moved out of the arena of scientific debate, and into the arena of consumer activism". This 
statement is based on the increasing presence of consumer groups on the internet and other open 
sources whtch question the way food producing animals are kept and raised . In Europe the ban on 
antimicrobial growth promoters (AGP) was started in Sweden and Denmark. The results were a 
drastic reduction in the overall tonnage in preventive antimicrobials, with a shift to more therapeutic 
use of antimtcrobials especially against enteric diseases. Since then, an increase in overall 
antibiotic usage has been reported in Denmark (Danmap 2005). New problems have arisen with 
the link between Methicillin resistant Staphylococcus Aureus bacteria and swine production (Voss 
et al. 2005). This problem has recently led to media coverage on national televiston in the 
Netherlands (Zembla 2006). 
The use of vaccines in swine production has demonstrated over the years to be a good alternative 
for antibiotics for many diseases. In the year 2000 Boehringer lngelheim introduced Enterisol® 
ilettis, the first and only vaccine against ileitis caused by Lawsonia intrace/lularis, in the United 
States market. Since then. this vaccine has obtained marketing authorisation in most of the major 
pig producing countries throughout the world. In multiple trials the potential of Enterisol® ileitis for 
the reduction of antibtotics is investigated. 
Study 1 - Mexico 
Materials and methods 
This study was performed in northern Mexico. The production system was a multiple-site farm with 
4000 sows. A total of 11 weekly production batches were evaluated; 7 control groups and 4 
vacctnated groups. Production parameters were evaluated ustng standard statistical process 
control methods Criteria evaluated included: Average daily weight gain (ADWG), Feed efficiency 
(FE), Age at market, Weight at market, and Percent Culls. 
Treatment procedures for each group were as follows· 
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Group 1: The control group used a pulse feed 
medication program dunng the ent1re finishing 
phase {body weight in parenthases): 
• Tylosin 110 ppm/carbadox 55 ppm 
(12-25Kg). 
• Tylosin 88 ppm/carbadox 27.5 ppm 
(25-40kg) 
• Tylostn 40 ppm/salinomycin 60 ppm 
(40-60kg) 
Results 
Group 2: P1gs were g1ven a live vaccine 
against Lawsonia intracellu/aris (Enterisolt~ 
Ileitis), vaccinated at 5 weeks of age in the 
nursery by oral administration. Additionally 
a reduced pulse medication program was 
implemented: 
• Tylosin 88 ppm/carbadox 55 ppm 
(25-40 kg) 
• Salinomyc1n 60 ppm (40-60 kg). 
Vaccinated pigs grew nearly 15% faster than conventionally medicated p1gs (Table 1). 
Table 1: Production Parameters and % Improvement 
Control 
Number of pigs (n) 
AOWG (g) 
FC (kg/kg) 
Market Weight {kg) 
Market age (d) 
Mortality site 3 (%) 
Culls(%) 
14,752 
758 
2.65 
87.88 
143.91 
4.54 
7.16 
Vx El 
8,145 
863 
2.60 
98.33 
139.05 
3 56 
3.79 
Dif 
+ 105 
- 0.05 
+10.45 
-4.86 
-0.98 
-3.37 
% 
+ 14 
- 2 
+ 12 
-3 
- 22 
-47 
Other parameters showing improvement include mortality, market we1ght and age, and cull rates 
Feed efficiency rema1ned unchanged even with total antimicrobial use reduced by 35% in 
vaccmated p1gs. 
Figure 1: Stat1st1cal Process Control (SPC) chart of AOWG pre and post vaccmahon. 
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Study 2 - USA 
Materials and methods 
A production system, typ1cal for the Midwestern U S, ra1ses approximately 2 5 M p1gs per year, out 
of a total US product1on of 1 00 M p1gs. The average sow farm s1ze 1s 4000 sows, with 
approximately 1500 new g1lts per farm per year Nursery and finishers are housed separately off 
site (multi-site production) Most finishing barns have deep pig manure storage over slatted noors, 
though 20% are shallow p1ts w1th "pull plug" systems In this large a production system, health 
controls, like any management programs, must be standardized, simple and repeatable to apply, 
and deliver cons1stent results, with little added treatments needed 
The h1story of enteric disease in the pigs mcluded all common pathogens seen in commercial p1g 
production - feed tnduced diarrhoea, gastnc ulcers, Salmonellosis, PCV-2, nonspec1fic colitis, 
hemorrhagic bowel syndrome, tors1ons and endemic TGE (transmissible gastroenteritis virus) 
These conditions were diagnosed by routine pathology and histopathology Both the 
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chrome/Proliferative Intestinal Adenomatosis (PIA) form and acute/Porcme Haemorrhagic 
Enteropathy (PHE) form are present m the system. Chronic diarrhoea h1stoncally began in 
commercial p1gs from 70 kg/150 lb to market, in the finishing barn. Hemorrhagic ileitis would occur 
1n some groups of p1gs around the first marketing cut, and 1n replacement gilts after placement into 
sow farms, at around 33 weeks of age. 
Control of Lawsonia intracellularis and other enteric diseases was attempted w1th feed grade 
medications In nursery p1gs, a system of carbadox, tiamulln/chlortetracycline and chlortetracycline 
alone was used. Th1s cont1nues today for 1ts broad spectrum respiratory and enteric benefit. 
Control of Lawsoma mtracel/ulans 1n finishing was based on several combinations of tylos1n, either 
at 100 ppm followed by 40 ppm, or 40 ppm continuously from 35 to 60 kg Breaks on th1s 
med1callon program occurred frequently, at an average of 70 or more enteric cases per month. 
Water soluble tylosin was used as the first treatment option. When cases would not respond, water 
therapy was changed to tiamulin. 
The goal for use of Enterisol® Ileitis was to reduce overall m-feed and water medication use, and, 
with Similar cost, Improve climcal control of disease m both h1gh value replacement gilts and 
fin1sh1ng p1gs. Replacement gilts were the first target for vaccination given the1r cost and the poor 
response to treatment of PHE cases. Vaccination of these animals began in 2001 . Follow1ng 
success in these animals, vacc1ne was tested m fin1sh1ng p1gs 1n 2002, with pigs vaccinated at 12-
14 weeks of age, JUSt followmg placement 1nto finishing. 
Results 
Vaccmahon has dramatically altered the feed medication program m finish1ng pigs and 
replacement gilts. Rout1ne use of both m-feed tylosin as well as growth promot1ng antibiotics has 
dropped to zero (see figure 2). The numbers of groups needing treatment for diarrhoea of any k1nd 
has been reduced over 75% (<15 cases/month now) even with the removal of all in-feed 
medications (1 00 % reduction). This has made health management much Simpler at the field 
superv1sor level, as well as in the feed mill. 
Figure 2 Effect of Entensol 1le1t1s vaccination on the use of feed grade tylos1n 
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Study 3 - Germany 
Materials and Methods 
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This long1tud1nal study was executed in a farrow-to-fin1sh farm of 1 600 sows and 10 000 fattemng 
places The control group consisted of 16,032 pigs out of 32 fattening groups that were 
slaughtered between November 2004 and July 2005 The 13,848 slaughtered, Entensol 1le1t1s 
vacc1nated pigs belonged to 27 groups They reached slaughter between May and November 
2005 All p1gs were housed under identical cond1t1ons The mon1tored parameters for the fatten1ng 
penod were ADWG (average da1ly we1ght gain), FC (Feed conversion ratio), mortality, and amount 
of ant1b1ot1c used aga1nst enteric diseases (AB use) The gross marg1n (GM) md1cates the possible 
economical benefit of the vaccination based on prior performance parameters 
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Results 
Table 2 summarizes the results , which showed significant Improvement 1n all parameters. 
Not only a reduction of the overall level of antibiotic use is shown, but additionally to table 2 an 
increased level of control 1n p1g production in this farm is seen since vaccination started. 
Furthermore, an economic benefit, expressed as Gross Margin of € 6.37 was generated. 
Table 2: Average growth performances, antibiotic use and Gross Margin (GM) in vaccinated 
pigs versus non-vaccinated controls. 
Control 
ADWG g/day 738 
FCR g/g 3.16 
Mortality % 4 
AB use Kg/group • 2.23 
Av GM I p1g (€) 25.34 
• AB use for therapeutic treatment of enteric diseases 
Vaccinated 
766 
2.98 
2.8 
1 03 
31 71 
Diff. 
+ 28 ••• 
-0.18 ... 
- 1.2 ••• 
- 53%*•• 
+6 37 
*"Assumptrons Feed pnce 170 €/T; Prglet price 57 € or 1.93 €/ Kg if< 30 Kg, Prg pnce 1 44 €/Kg 
••• Srgmficantly drfferent wrth a p-value < 0,001 
Conclusion 
The results show a broad improvement 1n groups of vacc~nated p1gs Even with a reduction of 
antimicrobial use, p1gs grew faster and more consrstently. 
These studies demonstrated that producers may have the option of eliminating fin1sh1ng 
dietary antimrcrobial use while reduc1ng 1nput costs and maintaining performance similar to or 
better than continuously medicated, non-vaccinated pigs. An overall reduction of 35 to 100 
percent of In-feed ant1b10t1cs was realized . 
As restrictions on ant1mrcrob1al use continue to ~ncrease , pork producers will need more 
opt1ons for con troll ing diseases like Ileitis which have traditionally accounted for much of the 
need for ant1mrcrobial use Use of Entensol ileitis to control ileitis is a b1olog1cally feas1ble, 
environmentally responsible and economically attractive alternative to cont~nuous feeding of 
antim1crob1als 
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